Danpharmacy ApS: Financial statements 2021
CVR: 39361337
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Danpharmacy ApS (CVR 39361337) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -3,200 and a net result of DKK -20,949 compared with DKK -28,065 the year before. Equity in the 2021 report amounted to DKK 23,706. The solvency ratio was 17.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -3,200
- Profit/Loss
- DKK -20,949
- Equity
- DKK 23,706
- Total Assets
- DKK 135,089
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -3K | -21K | 24K | 1 |
| 2020 | - | -9K | -28K | 45K | 1 |
| 2019 | - | 37K | 28K | 73K | 1 |
| 2018 | - | 5K | -5K | 45K | 1 |
Official annual report
Find more companies like Danpharmacy ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Danpharmacy ApS has published its annual report for 2020. Gross profit came to DKK -9,225, and the net result was DKK -28,065.
About Danpharmacy ApS
Danpharmacy ApS was a Danish company of the type Anpartsselskab based in Næstved, founded in 2018. The company has been dissolved on 24 June 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. According to the 2022 annual report, the company had an average of 1 employee. In 2022, the company reported a gross profit of DKK -1,370 and a net result of DKK -19,124 compared with DKK -20,949 the year before. Equity in the 2022 report amounted to DKK 4,583.